Fortress Biotech’s Majority-Controlled Subsidiary, Journey Medical Corporation, Receives FDA Approval for Emrosi™ for Rosacea Treatment
Fortress Biotech, Inc. (NASDAQ: FBIO) announced through its majority-controlled subsidiary, Journey Medical Corporation, that the U.S. Food and Drug Administration (FDA) has approved Emrosiâ„¢ ...
GlobalData on MSN17h
FDA approves Journey Medical’s rosacea treatment Emrosi
The US’ Food and Drug Administration (FDA) has approved Journey Medical’s Emrosi, the brand name for its 40mg minocycline ...
dermatologyadvisor15h
Emrosi Approved to Treat Inflammatory Lesions of Rosacea
The FDA approved Emrosi (minocycline hydrochloride extended-release capsules) for the treatment of inflammatory lesions of rosacea in adults.
The New York Times19h
World News
Tens of thousands of U.S. citizens live in the Israeli-occupied territory, on opposing sides of an entrenched conflict, where neither Palestinians nor Israelis have much enthusiasm for Kamala ...
STAT1d
STAT — Reporting from the frontiers of health and medicine
STAT Plus: Medicare Advantage insurers ramped up use of technology to deny claims, Senate investigation shows ...
The Thaiger17h
Phuket News
Two tragic incidents in Phuket resulted in the drowning deaths of a five year old Chinese boy and a 43 year old British tourist, police confirmed yesterday. Karon Police were notified by Chalong ...